ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients

Detalhes bibliográficos
Autor(a) principal: Viana Filho,José Maria Chagas
Data de Publicação: 2021
Outros Autores: Coêlho,Marina de Castro, Ribeiro,Isabella Lima Arrais, Persuhn,Darlene Camati, Valença,Ana Maria Gondim, Oliveira,Naila Francis Paulo de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Dental Journal
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402021000200014
Resumo: Abstract The study investigated the relationship between genetic polymorphisms and the development of oral mucositis in pediatric patients undergoing chemotherapy involving methotrexate. A longitudinal study was conducted with 64 patients, and oral mucositis was evaluated by the modified Oral Assessment Guide, which aims to diagnose and classify oral mucositis. Epithelial cells were obtained by mouthwash and DNA was extracted. The polymorphisms MTHFR (rs1801133), DNMT3B (rs2424913), ABCC2 (rs717620), ABCG2 (rs2231137) and ABCG2 (rs2231142) were analyzed by PCR-RFLP method. Demographic, hematological and biochemical data were collected from medical records. Statistical analysis was performed using the SPSS software adopting a p-value of 0.05. Male sex predominated (56.2%), and the mean age was 10.8 years (± 4.9). Oral mucositis affected 65.6% of the patients, of which 61.9% developed the severe form of the disease. For the ABCG2 gene (rs2231142), the rare A allele and CA genotype were more frequent in individuals with mucositis (p= 0.02; RR = 0.60; CI = 0.387 - 0.813). The severity of the disease was mainly observed in younger patients (median = 9 years; p=0.02). Patients with severe oral mucositis presented lower leukocytes count (median = 2.150 mm3) compared to patients with the mild/moderate form (median = 4.200 mm3; p=0.03). Female patients and each 10,000-platelet increase were protective factors against the onset of oral mucositis (p=0.02). It is concluded that rs2231142 polymorphism increases the likelihood of oral mucositis and younger patients and patients with low leukocytes counts are more likely to develop severe form.
id FUNORP-1_ff3a6b2e3a26ed4955f96bd529dab127
oai_identifier_str oai:scielo:S0103-64402021000200014
network_acronym_str FUNORP-1
network_name_str Brazilian Dental Journal
repository_id_str
spelling ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patientsOral mucosaMucositisPolymorphismChildrenChemotherapyAbstract The study investigated the relationship between genetic polymorphisms and the development of oral mucositis in pediatric patients undergoing chemotherapy involving methotrexate. A longitudinal study was conducted with 64 patients, and oral mucositis was evaluated by the modified Oral Assessment Guide, which aims to diagnose and classify oral mucositis. Epithelial cells were obtained by mouthwash and DNA was extracted. The polymorphisms MTHFR (rs1801133), DNMT3B (rs2424913), ABCC2 (rs717620), ABCG2 (rs2231137) and ABCG2 (rs2231142) were analyzed by PCR-RFLP method. Demographic, hematological and biochemical data were collected from medical records. Statistical analysis was performed using the SPSS software adopting a p-value of 0.05. Male sex predominated (56.2%), and the mean age was 10.8 years (± 4.9). Oral mucositis affected 65.6% of the patients, of which 61.9% developed the severe form of the disease. For the ABCG2 gene (rs2231142), the rare A allele and CA genotype were more frequent in individuals with mucositis (p= 0.02; RR = 0.60; CI = 0.387 - 0.813). The severity of the disease was mainly observed in younger patients (median = 9 years; p=0.02). Patients with severe oral mucositis presented lower leukocytes count (median = 2.150 mm3) compared to patients with the mild/moderate form (median = 4.200 mm3; p=0.03). Female patients and each 10,000-platelet increase were protective factors against the onset of oral mucositis (p=0.02). It is concluded that rs2231142 polymorphism increases the likelihood of oral mucositis and younger patients and patients with low leukocytes counts are more likely to develop severe form.Fundação Odontológica de Ribeirão Preto2021-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402021000200014Brazilian Dental Journal v.32 n.2 2021reponame:Brazilian Dental Journalinstname:Fundação Odontológica de Ribeirão Preto (FUNORP)instacron:FUNORP10.1590/0103-6440202103768info:eu-repo/semantics/openAccessViana Filho,José Maria ChagasCoêlho,Marina de CastroRibeiro,Isabella Lima ArraisPersuhn,Darlene CamatiValença,Ana Maria GondimOliveira,Naila Francis Paulo deeng2021-09-29T00:00:00Zoai:scielo:S0103-64402021000200014Revistahttps://www.scielo.br/j/bdj/https://old.scielo.br/oai/scielo-oai.phpbdj@forp.usp.br||sergio@fosjc.unesp.br1806-47600103-6440opendoar:2021-09-29T00:00Brazilian Dental Journal - Fundação Odontológica de Ribeirão Preto (FUNORP)false
dc.title.none.fl_str_mv ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
title ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
spellingShingle ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
Viana Filho,José Maria Chagas
Oral mucosa
Mucositis
Polymorphism
Children
Chemotherapy
title_short ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
title_full ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
title_fullStr ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
title_full_unstemmed ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
title_sort ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients
author Viana Filho,José Maria Chagas
author_facet Viana Filho,José Maria Chagas
Coêlho,Marina de Castro
Ribeiro,Isabella Lima Arrais
Persuhn,Darlene Camati
Valença,Ana Maria Gondim
Oliveira,Naila Francis Paulo de
author_role author
author2 Coêlho,Marina de Castro
Ribeiro,Isabella Lima Arrais
Persuhn,Darlene Camati
Valença,Ana Maria Gondim
Oliveira,Naila Francis Paulo de
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Viana Filho,José Maria Chagas
Coêlho,Marina de Castro
Ribeiro,Isabella Lima Arrais
Persuhn,Darlene Camati
Valença,Ana Maria Gondim
Oliveira,Naila Francis Paulo de
dc.subject.por.fl_str_mv Oral mucosa
Mucositis
Polymorphism
Children
Chemotherapy
topic Oral mucosa
Mucositis
Polymorphism
Children
Chemotherapy
description Abstract The study investigated the relationship between genetic polymorphisms and the development of oral mucositis in pediatric patients undergoing chemotherapy involving methotrexate. A longitudinal study was conducted with 64 patients, and oral mucositis was evaluated by the modified Oral Assessment Guide, which aims to diagnose and classify oral mucositis. Epithelial cells were obtained by mouthwash and DNA was extracted. The polymorphisms MTHFR (rs1801133), DNMT3B (rs2424913), ABCC2 (rs717620), ABCG2 (rs2231137) and ABCG2 (rs2231142) were analyzed by PCR-RFLP method. Demographic, hematological and biochemical data were collected from medical records. Statistical analysis was performed using the SPSS software adopting a p-value of 0.05. Male sex predominated (56.2%), and the mean age was 10.8 years (± 4.9). Oral mucositis affected 65.6% of the patients, of which 61.9% developed the severe form of the disease. For the ABCG2 gene (rs2231142), the rare A allele and CA genotype were more frequent in individuals with mucositis (p= 0.02; RR = 0.60; CI = 0.387 - 0.813). The severity of the disease was mainly observed in younger patients (median = 9 years; p=0.02). Patients with severe oral mucositis presented lower leukocytes count (median = 2.150 mm3) compared to patients with the mild/moderate form (median = 4.200 mm3; p=0.03). Female patients and each 10,000-platelet increase were protective factors against the onset of oral mucositis (p=0.02). It is concluded that rs2231142 polymorphism increases the likelihood of oral mucositis and younger patients and patients with low leukocytes counts are more likely to develop severe form.
publishDate 2021
dc.date.none.fl_str_mv 2021-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402021000200014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402021000200014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0103-6440202103768
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Fundação Odontológica de Ribeirão Preto
publisher.none.fl_str_mv Fundação Odontológica de Ribeirão Preto
dc.source.none.fl_str_mv Brazilian Dental Journal v.32 n.2 2021
reponame:Brazilian Dental Journal
instname:Fundação Odontológica de Ribeirão Preto (FUNORP)
instacron:FUNORP
instname_str Fundação Odontológica de Ribeirão Preto (FUNORP)
instacron_str FUNORP
institution FUNORP
reponame_str Brazilian Dental Journal
collection Brazilian Dental Journal
repository.name.fl_str_mv Brazilian Dental Journal - Fundação Odontológica de Ribeirão Preto (FUNORP)
repository.mail.fl_str_mv bdj@forp.usp.br||sergio@fosjc.unesp.br
_version_ 1754204096222461952